One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Environment and Systemic Autoimmune Rheumatic Diseases: What Do We Know After More Than 15 Years of Research?
doi : 10.1002/art.43260
Making the Most of Advanced Computed Tomography Imaging Techniques for Medical Decision-Making in Arthritis Imaging
doi : 10.1002/art.43342
Trimethoprim/Sulfamethoxazole in Clinical Trials for Granulomatosis With Polyangiitis
doi : 10.1002/art.43360
Some More Equal Than Others: The Divergence of Cardiac Risk in the Use of Nonsteroidal Anti-Inflammatory Drugs Versus Colchicine for Treating and Preventing Gout
doi : 10.1002/art.43324
Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities
doi : 10.1002/art.43258
The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients
doi : 10.1002/art.43248
Clinical Impact of Multiparametric Contrast-Enhanced Dual-Energy Computed Tomography in Arthritis Imaging: A Prospective Single-Center Study
doi : 10.1002/art.43270
Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data
doi : 10.1002/art.43255
Efficacy and Safety of ABBV-154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo-Controlled Trial
doi : 10.1002/art.43266
Associations Between Changes in Pain Sensitization and Disease Activity Following Disease-Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis
doi : 10.1002/art.43265
ADAM9 Promotes Glycolysis in Th17 Cells and Autoimmunity Through Activation of IGF-1 Signaling
doi : 10.1002/art.43313
C3a–C3aR1–Mediated Interactions Between Fibroblast–Like Synoviocytes and Macrophages Promote the Progression of Rheumatoid Arthritis
doi : 10.1002/art.43319
Orchestration of Skin Pathology in Cutaneous Lupus Erythematosus by HLA Class I Down-Regulated Senescent Epidermal Basal Cells
doi : 10.1002/art.43244
Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo-Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon-Associated Gene Expression and Cytokines
doi : 10.1002/art.43271
A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis
doi : 10.1002/art.43272
Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis
doi : 10.1002/art.43262
Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China
doi : 10.1002/art.43261
Comparative Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drug Versus Colchicine Use When Initiating Urate-Lowering Therapy Among Patients With Gout: Target Trial Emulations
doi : 10.1002/art.43259
Systemic Autoimmune Rheumatic Disease Risk: Association With Long-Term Exposure to Fine Particulate Matter
doi : 10.1002/art.43276
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria
doi : 10.1002/art.43263
Short-term risk of cardiovascular events in people newly diagnosed with gout: comment on the article by Cipolletta et al
doi : 10.1002/art.43163
Circulating interferon alpha protein measured with digital enzyme-linked immunosorbent assay as a biomarker for modified Rodnan skin score progression in limited systemic sclerosis: comment on the article from Di Donato et al
doi : 10.1002/art.43226
Limitations of machine learning–based feature importance in osteoarthritis biomarker discovery: comment on the article by Kang et al
doi : 10.1002/art.43222
Variation in the incidence of juvenile idiopathic arthritis in Norway as latitude changes: are we rigorous enough? Comment on the article by Hestetun et al
doi : 10.1002/art.43240
Reassessing biomarker signatures in RA-ILD and the impact of gender, environment, and disease activity: comment on the article by Wheeler et al
doi : 10.1002/art.43245
Thigh intramuscular fat infiltration as a risk factor for knee and hip osteoarthritis: comment on the article by Weng et al
doi : 10.1002/art.43246
Drivers of subclinical vascular disease in systemic lupus erythematosus: comment on the article by Oliveira et al
doi : 10.1002/art.43249
